These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients. Khristi J, Mey U, Kirfel J, Schmidt-Wolf IG, Gütgemann I. Ann Hematol; 2013 Nov; 92(11):1565-7. PubMed ID: 23558907 [No Abstract] [Full Text] [Related]
6. Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. Hall PA, D'Ardenne AJ. J Clin Pathol; 1987 Nov; 40(11):1298-304. PubMed ID: 3320093 [Abstract] [Full Text] [Related]
7. [Diagnostics, classification and high dose chemotherapy in non Hodgkin's and Hodgkin's lymphoma]. Nowak WS, Jurczak W, Wójcik M, Skotnicki AB. Przegl Lek; 1999 Nov; 56 Suppl 1():73-9. PubMed ID: 10494187 [Abstract] [Full Text] [Related]
8. [Bone manifestations disclosing Hodgkin's disease and non-Hodgkin's malignant lymphoma. Analysis of 11 cases]. Gaudin P, Troussier B, Zagala A, Pillon P, Rose-Pittet L, Le Bas JF, Pegourie B, Phelip X. Rev Rhum Mal Osteoartic; 1989 Nov; 56(11):745-51. PubMed ID: 2609087 [Abstract] [Full Text] [Related]
9. Hodgkin's and non-Hodgkin's lymphomas. Rademaker J. Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624 [Abstract] [Full Text] [Related]
10. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases? Idrees R, Ahmad Z, Qureshi A, Ahsan A, Pervez S. J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908 [Abstract] [Full Text] [Related]